openPR Logo
Press release

Human Growth Hormone Market – The analysis offers strategies and analyzes By Leading Players: Pfizer Inc., Novo Nordisk, Genetech Inc., Merck & Co., Eli Lilly And Company, Sandoz International GmbH

04-19-2019 09:47 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Human Growth Hormone

Human Growth Hormone

Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has an orphan drug designation in the U.S. and Europe for adults and children with growth hormone deficiency.

Request for a sample of this research report @ https://www.coherentmarketinsights.com/insight/request-sample/1859

Robust pipeline is also expected to support the growth in human growth hormone market size. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults. MOD-4023 sponsored by Opko Biologics, an Israel-based company, completed phase 2 clinical trials in 2015. High prevalence of growth hormone deficiency is another factor boosting growth of human growth hormone market. According to a survey conducted by the National Organization for Rare Diseases (NORA) in 2015, over 10,000 children and 50,000 adults have growth hormone deficiency in the U.S.

Europe human growth hormone market is expected to witness significant growth due to mergers and acquisitions. For instance, in 2017, Ferring Pharmaceuticals S.A., a pharmaceutical company, acquired a product i.e. Zoma Jet of Antares Pharma Inc, a pharmaceutical company. Zoma Jet is a needle free auto injectable device. Ferring Pharmaceuticals S.A acquired Zoma Jet in order to increase use of Zomacton (Injectable somatropin hGH). Zoma Jet is used to deliver Zomacton for the treatment of growth hormone deficiency in children and Turner’s syndrome in girls.

To get holistic SAMPLE with TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1859

By acquiring the injectable device Zoma Jet, would eventually lead to increase in use of the drug, Zomacton, which will further encourage Ferring Pharmaceuticals to develop better treatment options for growth hormone deficiency, thereby resulting in growth of the human growth hormone market. Asia Pacific is expected to grow over the forecast period due to robust pipeline. For instance, Cinna Tropin sponsored by Cinnagen, an Iran-based company, completed phase 3 clinical trials in 2017. This drug is used to treat idiopathic short stature in children and adults.

North America is expected to hold dominant position in the global human growth hormone market due to new biosimilar approvals by Health Canada for biosimilar of human growth hormone drugs. For instance, in 2015, Health Canada approved the first generic biological called as PROmnitrope. PROmnitrope is a recombinant human growth hormone used to treat deficiency of growth hormone in adults as well as children. This can encourage new generic version of drugs, thereby fueling the human growth hormone market growth.

Make an inquiry for purchasing this report @ https://www.coherentmarketinsights.com/insight/buy-now/1859

However, strict rules and regulations for the use of human growth hormone by athletes and sports professionals is expected to restrain growth of human growth hormone market. The Food and Drug Administration (FDA) and the International Olympic Committee had banned the use of human growth hormone for sports professionals in 2006.

Key players operating in the global human growth hormone market include Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Growth Hormone Market – The analysis offers strategies and analyzes By Leading Players: Pfizer Inc., Novo Nordisk, Genetech Inc., Merck & Co., Eli Lilly And Company, Sandoz International GmbH here

News-ID: 1710578 • Views: 605

More Releases from Coherent Market Insights

Embedded Security For Internet of Things (IoT) Market 2022 : Trends, Business Gr …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗲𝗺𝗯𝗲𝗱𝗱𝗲𝗱 𝘀𝗲𝗰𝘂𝗿𝗶𝘁𝘆 𝗳𝗼𝗿 𝗶𝗻𝘁𝗲𝗿𝗻𝗲𝘁 𝗼𝗳 𝘁𝗵𝗶𝗻𝗴𝘀 (𝗜𝗼𝗧) 𝗺𝗮𝗿𝗸𝗲𝘁 𝘄𝗮𝘀 𝗲𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝗱 𝘁𝗼 𝗮𝗰𝗰𝗼𝘂𝗻𝘁 𝗳𝗼𝗿 𝗨𝗦$ 𝟯,𝟮𝟮𝟱.𝟱 𝗠𝗻 𝗶𝗻 𝟮𝟬𝟭𝟴 𝗮𝗻𝗱 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗴𝗿𝗼𝘄 𝗮𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟭𝟰.𝟲% 𝗱𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝗲𝗱 𝗽𝗲𝗿𝗶𝗼𝗱 (𝟮𝟬𝟭𝟵-𝟮𝟬𝟮𝟳) Summary of the Report - CMI's latest report, global "Embedded Security For Internet of Things (IoT) Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints,
Transportation Predictive Analytics and Simulation Market Overview, Growth Oppor …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗧𝗿𝗮𝗻𝘀𝗽𝗼𝗿𝘁𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝗮𝗻𝗱 𝗦𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟴.𝟵% 𝗗𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝗲𝗱 𝗽𝗲𝗿𝗶𝗼𝗱 (𝟮𝟬𝟭𝟵-𝟮𝟬𝟮𝟳) Summary of the Report - CMI's latest report, global "Transportation Predictive Analytics and Simulation Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Cubic Corporation, T-Systems International GmbH, IBM Corporation, Tiger
Distributed Fiber Optic Sensor Market is Expected to Record the Massive Growth, …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗱𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗲𝗱 𝗳𝗶𝗯𝗲𝗿 𝗼𝗽𝘁𝗶𝗰 𝘀𝗲𝗻𝘀𝗼𝗿 𝗺𝗮𝗿𝗸𝗲𝘁 𝘄𝗮𝘀 𝘃𝗮𝗹𝘂𝗲𝗱 𝗮𝘁 𝗨𝗦$ 𝟭,𝟱𝟮𝟵.𝟴 𝗠𝗻 𝗶𝗻 𝟮𝟬𝟮𝟬 𝗮𝗻𝗱 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗿𝗲𝗮𝗰𝗵 𝗨𝗦$ 𝟯,𝟬𝟭𝟱.𝟲 𝗠𝗻 𝗯𝘆 𝟮𝟬𝟮𝟳 𝗮𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟭𝟬.𝟮% 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝟮𝟬𝟮𝟭 𝗮𝗻𝗱 𝟮𝟬𝟮𝟳. Summary of the Report - CMI's latest report, global "Distributed Fiber Optic Sensor Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment
GCC WIFI Chipset Market 2022 Global Leading Companies Analysis, Outlook, Revenue …
Summary of the Report - CMI's latest report, global "GCC WIFI Chipset Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Broadcom, MediaTek Inc., Marvell, Intel Corporation, Realtek Semiconductor Corp., and Qualcomm Technologies, Inc. among others.. ▪ Profiles of 5 leading companies in the industry - overview, key strategies, financials, and products ▪

All 5 Releases


More Releases for Zoma

Human Growth Hormone Market - Cell Reproduction, and Cell Regeneration in humans …
Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has
Human Growth Hormone Market to Witness a Healthy Growth By Leading Players Pfize …
Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has
Human Growth Hormone Market- New mergers and Acquisitions By Leading Compaines:
Robust pipeline is also expected to support the growth in human growth hormone market size. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults. MOD-4023 sponsored by Opko Biologics, an Israel-based company, completed phase 2 clinical trials in 2015. High prevalence of growth hormone deficiency is another factor
Human Growth Hormone Market- Healthcare sector By Current Industry: Pfizer Inc., …
Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has
Human Growth Hormone Market Revenue Opportunies By Key Vendors Pfizer Inc., Novo …
Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has
Human Growth Hormone Market Development Trends And Major Key Players Pfizer, Gen …
Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has